Chicos Fas, Inc. (CHS) Reports In-Line Q4 EPS
Get Alerts CHS Hot Sheet
Price: $7.59 --0%
Financial Fact:
Cost of goods sold: 366.62M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Cost of goods sold: 366.62M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Chicos Fas, Inc. (NYSE: CHS) reported Q4 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $651.9 million versus the consensus estimate of $665.57 million.
The Company's goal has been to establish financial targets that are both sustainable and reflect strong growth metrics. The Company believes that by delivering on its long-term objectives to increase sales by a low double-digit percentage and diluted earnings per share by a mid-teen percentage over a meaningful period of time, the Company will provide its shareholders with substantial value.Consistent with these objectives, the Company announced today several strategic investments in 2013 to fuel future growth, including omni-channel capabilities, expansion into Canada, and opening its first Boston Proper stores.
For earnings history and earnings-related data on Chicos Fas, Inc. (CHS) click here.
The Company's goal has been to establish financial targets that are both sustainable and reflect strong growth metrics. The Company believes that by delivering on its long-term objectives to increase sales by a low double-digit percentage and diluted earnings per share by a mid-teen percentage over a meaningful period of time, the Company will provide its shareholders with substantial value.Consistent with these objectives, the Company announced today several strategic investments in 2013 to fuel future growth, including omni-channel capabilities, expansion into Canada, and opening its first Boston Proper stores.
For earnings history and earnings-related data on Chicos Fas, Inc. (CHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share